Aleksandar D Sekulic, MD, PhD

  • 3400 Citations
  • 23 Scopus h-Index
19962019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Aleksandar D Sekulic is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
HhAntag691 Medicine & Life Sciences
Basal Cell Carcinoma Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Skin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Safety Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Small Cell Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 3400 Citations
  • 23 Scopus h-Index
  • 54 Article
  • 2 Chapter
  • 1 Comment/debate

Correction to: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study (BMC Cancer. (2017) 17 (332) DOI: 10.1186/s12885-017-3286-5)

Sekulic, A. D., Migden, M. R., Basset-Seguin, N., Garbe, C., Gesierich, A., Lao, C. D., Miller, C., Mortier, L., Murrell, D. F., Hamid, O., Quevedo, J. F., Hou, J., McKenna, E., Dimier, N., Williams, S., Schadendorf, D. & Hauschild, A., Apr 18 2019, In : BMC cancer. 19, 1, 366.

Research output: Contribution to journalComment/debate

Open Access
HhAntag691
Basal Cell Carcinoma
Publications
Safety
Neoplasms

The prognostic value of inositol polyphosphate 5-phosphatase in cutaneous squamous cell carcinoma

Cumsky, H. J. L., Costello, C. M., Zhang, N., Butterfield, R., Buras, M. R., Schmidt, J. E., Drenner, K., Nelson, S. A., Ochoa, S. A., Baum, C., Pittelkow, M. R., DiCaudo, D. J., Sekulic, A. D. & Mangold, A., Mar 1 2019, In : Journal of the American Academy of Dermatology. 80, 3, p. 626-632.e1

Research output: Contribution to journalArticle

Squamous Cell Carcinoma
Skin
Neoplasms
Actinic Keratosis
Inositol Polyphosphate 5-Phosphatases
5 Citations (Scopus)

Chemoprevention agents for melanoma: a path forward into phase 3 clinical trials

Jeter, J. M., Bowles, T. L., Curiel-Lewandrowski, C., Swetter, S. M., Filipp, F. V., Abdel-Malek, Z. A., Geskin, L. J., Brewer, J. D., Arbiser, J. L., Gershenwald, J. E., Chu, E. Y., Kirkwood, J. M., Box, N. F., Funchain, P., Fisher, D. E., Kendra, K. L., Marghoob, A. A., Chen, S. C., Ming, M. E., Albertini, M. R. & 22 others, Vetto, J. T., Margolin, K. A., Pagoto, S. L., Hay, J. L., Grossman, D., Ellis, D. L., Kashani-Sabet, M., Mangold, A., Markovic, S. N., Nelson, K. C., Powers, J. G., Robinson, J. K., Sahni, D., Sekulic, A. D., Sondak, V. K., Wei, M. L., Zager, J. S., Dellavalle, R. P., Thompson, J. A., Weinstock, M. A., Leachman, S. A. & Cassidy, P. B., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Phase III Clinical Trials
Chemoprevention
Melanoma
Drug Repositioning
Biological Products
1 Citation (Scopus)

Clinical and histopathologic features of paraneoplastic granuloma annulare in association with solid organ malignancies: A case–control study

Mangold, A., Cumsky, H. J. L., Costello, C. M., Xie, D. Y., Buras, M. R., Nelson, S. A., DiCaudo, D. J., Sekulic, A. D. & Pittelkow, M. R., Jan 1 2018, (Accepted/In press) In : Journal of the American Academy of Dermatology.

Research output: Contribution to journalArticle

Granuloma Annulare
Neoplasms
Therapeutics
14 Citations (Scopus)

Evaluation of pre-analytical factors affecting plasma DNA analysis

Markus, H., Contente-Cuomo, T., Farooq, M., Liang, W. S., Borad, M. J., Sivakumar, S., Gollins, S., Tran, N., Dhruv, H. D., Berens, M. E., Bryce, A. H., Sekulic, A. D., Ribas, A., Trent, J. M., Lorusso, P. M. & Murtaza, M., Dec 1 2018, In : Scientific Reports. 8, 1, 7375.

Research output: Contribution to journalArticle

DNA
cells
sampling
droplets
blood